Harbinger Health has raised $140 million to clinically validate a blood-based cancer screening test ahead of a planned launch in 2025. The test is designed to identify epigenetic changes that signal ...
CAMBRIDGE, Mass. & NASHVILLE, Tenn.--(BUSINESS WIRE)--Harbinger Health, a biotechnology company pioneering the detection of early cancer, and Sarah Cannon Research Institute (SCRI) announced today the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback